Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 11, 2025 • 8:01 AM ET

Date/Time Source News Release
05/27/2025 08:00 AM EDT GlobeNewswire Immutep's Efti with Radiotherapy & KEYTRUDA® (pembrolizumab) Meets Primary Endpoint in Phase II for Soft Tissue Sarcoma
05/15/2025 08:00 AM EDT GlobeNewswire Immutep's Efti with KEYTRUDA® (pembrolizumab) & Chemotherapy Achieves High Response Rates in First-Line Non-Small Cell Lung Cancer
05/05/2025 08:00 AM EDT GlobeNewswire Immutep's Efti in Combination with KEYTRUDA® (pembrolizumab) Drives Strong Overall Survival in Head and Neck Cancer with CPS <1
04/29/2025 08:00 AM EDT GlobeNewswire Immutep Quarterly Activities Report Q3 FY25
04/02/2025 08:00 AM EDT GlobeNewswire Immutep to Participate in Upcoming Investor Conferences
03/25/2025 08:00 AM EDT GlobeNewswire First Patient Dosed in Immutep's TACTI-004 Phase III Trial in First Line Non-Small Cell Lung Cancer
03/20/2025 08:00 AM EDT GlobeNewswire Immutep to Present Pivotal TACTI-004 Trial in Progress Poster at the European Lung Cancer Congress 2025
01/31/2025 08:00 AM EST GlobeNewswire Immutep Quarterly Activities Report Q2 FY25
01/22/2025 08:00 AM EST GlobeNewswire Patient Enrolment Completed for EFTISARC-NEO Phase II Trial
01/06/2025 08:00 AM EST GlobeNewswire Patient Enrolment Completed for INSIGHT-003
Page

Additional News

As of June 11, 2025 • 8:01 AM ET

Date/Time Source News Release
05/08/2025 08:46 AM EDT SeekingAlpha Immutep Limited: Surging On Positive Head And Neck Data
05/05/2025 02:00 PM EDT PRISM News PRISM Mid-Day Movers: Trial Results and FDA Fast Tracks Drive Indices Higher
05/05/2025 12:31 PM EDT PRISM News Immutep Surges 25% on Strong Survival Data for Efti + KEYTRUDA(R) in Head & Neck Cancer
05/05/2025 11:31 AM EDT InvestorBrandNetwork Immutep Ltd. (NASDAQ: IMMP) Sees Notable Increase in Monday Morning Market Activity
03/31/2025 11:50 AM EDT SeekingAlpha Immutep: A Small Company With A Pipeline Resembling Big Pharma
01/28/2025 04:37 PM EST SeekingAlpha Immutep Limited: Continuing To Make The Case For Eftilagimod
11/15/2024 03:18 PM EST SeekingAlpha Immutep: Potential Of Efti As New Standard Of Care For NSCLC Patients
11/14/2024 03:17 PM EST SeekingAlpha Immutep stock jumps 11% on positive data for eftilagimod alpha
10/25/2023 08:49 AM EDT SeekingAlpha Immutep receives about A$1.13M R&D tax incentive from Australian govt
10/05/2023 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, October 5th, 2023
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.